Tag Archives: Needle-Free Injector

SD Biotech Roundup: Wireless Sensor Prize, Zogenix, Sangart, & More

The X Prize Foundation’s Peter Diamandis came to San Diego to announce the formation of a new incentive prize competition, while a variety of companies disclosed new funding deals. It’s all part of our roundup of local life sciences news. —San Diego-based Sangart, which has been developing an oxygen-carrying compound for treating the effects of […]

Posted in National blog main, San Diego, San Diego blog main, San Diego top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on SD Biotech Roundup: Wireless Sensor Prize, Zogenix, Sangart, & More

Genomatica Files for IPO, Tandem Diabetes Raises $12M, Zogenix Looks to Raise Almost $50M, & More San Diego Life Sciences News

The big news for San Diego life sciences companies over the past week fell into two categories, raising money and winning regulatory approval. Either way, it’s all good news. —Genomatica, which genetically engineers microorganisms to produce industrial chemicals from renewable raw materials, has applied to raise $100 million through an IPO. The proceeds would be […]

Posted in National blog main, San Diego, San Diego blog main | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Genomatica Files for IPO, Tandem Diabetes Raises $12M, Zogenix Looks to Raise Almost $50M, & More San Diego Life Sciences News

Zogenix Pain Drug Meets Endpoint

San Diego-based Zogenix says its late-stage efficacy study of hydrocodone bitartrate (Zohydro) met the company’s intended goal, with patients reporting improved chronic pain relief compared to a placebo. The study also demonstrated that the drug candidate was safe and well-tolerated. If federal drug regulators approve the drug for the U.S. market, Zogenix says it could […]

Posted in National briefs, San Diego, San Diego briefs | Tagged , , , , , , , , , | 1 Comment

Biotech is Biggest Winner in Second-Quarter VC Funding, Zogenix Strategy Unfolds, Intellikine Builds Clinical Trial Capabilities, & More San Diego Life Sciences News

There’s been a deluge of venture capital news over the past week, and a flash flood of VC cash during the second quarter went mostly to San Diego’s life sciences sector. Our briefing begins now. —San Diego venture firms invested a total of $198.2 million in 29 local startups during the second quarter that ended […]

Posted in National blog main, San Diego, San Diego blog main | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Biotech is Biggest Winner in Second-Quarter VC Funding, Zogenix Strategy Unfolds, Intellikine Builds Clinical Trial Capabilities, & More San Diego Life Sciences News

Zogenix Files for IPO, Orexigen Licenses Obesity Drug to Takeda, ImThera Raises Capital For Sleep Apnea, & More San Diego Life Science News

The big news: San Diego’s Orexigen inked a marketing deal around its obesity drug compound whose value could soar into the billions of dollars. We’ve got that and the rest of San Diego’s life science news for you here. —Zogenix, the four-year-old San Diego startup that develops compounds for treating pain and central nervous system […]

Posted in National blog main, San Diego, San Diego blog main | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Zogenix Files for IPO, Orexigen Licenses Obesity Drug to Takeda, ImThera Raises Capital For Sleep Apnea, & More San Diego Life Science News